The convergence of cellular reprogramming, biomaterial innovation, and clinical translation is redefining modern medicine. Stem cell therapy and regenerative medicine form a transformative approach where damaged tissues and dysfunctional organs are repaired or replaced using the body's own regenerative capabilities. Whether derived from embryonic, induced pluripotent, or adult sources, stem cells can differentiate into various cell types under precise conditions. Coupled with bioactive scaffolds, these cells are being guided toward repairing cardiac tissue, regenerating cartilage, and even restoring spinal cord functions. Immunomodulation, homing signals, and paracrine signaling pathways are also being harnessed to enhance therapeutic efficacy. As clinical trials continue to report promising outcomes, ethical and regulatory discussions are evolving in parallel to ensure safety and accessibility. Stem cell therapy and regenerative medicine are now moving beyond proof-of-concept, finding tangible applications in orthopedics, ophthalmology, and beyond, with personalized medicine principles guiding their future implementation.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation